← back to search

Craig E. Gordon

Tufts University · US
Area of research
Hepatology · Epidemiology
Research interest
Research interests include Hepatitis C virus research, Liver Disease Diagnosis and Treatment, Renal Transplantation Outcomes and Treatments, and Renal Diseases and Glomerulopathies.
h-index
24
citations
2,516
works
70
NIH funding
primary concept
email

Recent publications

KDIGO 2025 clinical practice guideline for the evaluation, management, and treatment of autosomal dominant polycystic kidney disease (ADPKD): executive summary
Kidney International 2025cited by 78position: middledoi
Kidney Transplantation From Hepatitis C Virus–Infected Donors to Uninfected Recipients: A Systematic Review for the KDIGO 2022 Hepatitis C Clinical Practice Guideline Update
American Journal of Kidney Diseases 2023cited by 18position: firstdoi
Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C in Chronic Kidney Disease: Synopsis of the Kidney Disease: Improving Global Outcomes 2022 Clinical Practice Guideline
Annals of Internal Medicine 2023cited by 11position: middledoi
Executive Summary of the KDIGO 2022 Clinical Practice Guideline for the Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C in Chronic Kidney Disease
Kidney International 2022cited by 36position: middledoi
A Systematic Review of Direct-Acting Antivirals for Hepatitis C in Advanced CKD
Kidney International Reports 2022cited by 12position: lastdoi
Summary of the Kidney Disease: Improving Global Outcomes (KDIGO) Clinical Practice Guideline on the Evaluation and Management of Candidates for Kidney Transplantation
Transplantation 2020cited by 142position: middledoi
Advances in BK Virus Complications in Organ Transplantation and Beyond
Kidney Medicine 2020cited by 60position: middledoi
Non-immunological complications following kidney transplantation
F1000Research 2019cited by 41position: middledoi
Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C Virus Infection in Chronic Kidney Disease: Synopsis of the Kidney Disease: Improving Global Outcomes 2018 Clinical Practice Guideline
Annals of Internal Medicine 2019cited by 25position: firstdoi
Executive summary of the 2018 KDIGO Hepatitis C in CKD Guideline: welcoming advances in evaluation and management
Kidney International 2018cited by 86position: middledoi
Timing of hepatitis C virus infection treatment in kidney transplant candidates
Hemodialysis International 2018cited by 14position: lastdoi
Outcomes of bisphosphonate therapy in kidney transplant recipients: a systematic review and meta‐analysis
Clinical Transplantation 2016cited by 35position: lastdoi
Acetazolamide in Lithium-Induced Nephrogenic Diabetes Insipidus
New England Journal of Medicine 2016cited by 26position: firstdoi
Recapturing time: a practical approach to time management for physicians
Postgraduate Medical Journal 2014cited by 83position: firstdoi
Bleeding Complications of Native Kidney Biopsy: A Systematic Review and Meta-analysis
American Journal of Kidney Diseases 2012cited by 429position: lastdoi
Cinacalcet for the Treatment of Hyperparathyroidism in Kidney Transplant Recipients
Transplantation 2012cited by 61position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Jean Francis · Boston University6 papers (2012–2020)Michel Jadoul · UCLouvain6 papers (2018–2023)Paul Martin · University of Miami5 papers (2018–2023)Amy Earley · Lake Superior State University5 papers (2018–2023)Marina Berenguer · Hospital Universitari i Politècnic La Fe4 papers (2018–2023)Stanislas Pol · Groupe Hospitalier Cochin - Port-Royal, Hôtel-Dieu, Broca - La Collégiale4 papers (2018–2023)Fabrizio Fabrizi · Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico4 papers (2018–2023)Gaelen P. Adam · Brown University4 papers (2022–2023)Nassim Kamar · French Clinical Research Infrastructure Network4 papers (2018–2023)Bertram L. Kasiske · University of Minnesota3 papers (2018–2020)Abraham Cohen‐Bucay · Harvard University3 papers (2018–2020)Michael Cheung · Royal Children's Hospital3 papers (2019–2023)Mengyang Di · Fred Hutch Cancer Center2 papers (2018–2019) · 2 papers (2018–2019)Jacques Izopet · Laboratoire Epidémiologie et Analyses en Santé Publique : Risques, Maladies Chroniques et Handicaps2 papers (2018–2019)Ching‐Lung Lai · Novartis (China)2 papers (2018–2019) · 2 papers (2022–2023)David S. Goldberg · University of Miami2 papers (2022–2023)Jidong Jia · Tongji Hospital2 papers (2022–2023)Priti R. Patel · University of Maryland, College Park2 papers (2018–2019)